| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2001) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | 5N4SA4KQX9 |
| Parent Compound: | GALANTAMINE |
Structure
| InChI Key | QORVDGQLPPAFRS-XPSHAMGMSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C17H22BrNO3 |
| Molecular Weight | 368.27 |
| AlogP | 1.85 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 41.93 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 21.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Acetylcholinesterase inhibitor | DailyMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Dementia, Vascular | 3 | D015140 | ClinicalTrials |
| Schizophrenia | 3 | D012559 | ClinicalTrials |
| Cognitive Dysfunction | 3 | D060825 | ClinicalTrials |
| Mental Disorders | 3 | D001523 | ClinicalTrials |
| Frontotemporal Dementia | 2 | D057180 | ClinicalTrials |
Related Entries
Scaffolds
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 42944 |
| ChEMBL | CHEMBL1555 |
| EPA CompTox | DTXSID4052768 |
| FDA SRS | 5N4SA4KQX9 |
| Guide to Pharmacology | 6693 |
| KEGG | C08526 |
| PDB | GNT |
| PubChem | 121587 |
| SureChEMBL | SCHEMBL177993 |
| ZINC | ZINC00491073 |
CONTENTS